As Brexit starts to loom again, I fear an increasing range of poorly planned for risks will begin to emerge. This story tells us:
The government will restrict exports of key drugs, including those used for hormone replacement therapy (HRT), after manufacturing problems caused medicine shortages in the UK.
HRT stocks will remain in the country until the manufacturing issues are resolved.
The Department of Health and Social Care (DHSC) has also permitted pharmacists to provide different strengths of fluoxetine, an antidepressant, after most strengths of the drug went out of stock.
“I know how distressing medicine shortages can be for those who rely on drugs like HRT and it’s absolutely crucial patients can always access safe and effective treatments through the NHS,” said Matt Hancock, the Health Secretary.
“Helping the NHS is a priority for this Government, and people should be fully reassured that we will always act to ensure that there is an adequate supply of the medicine you need.”